NCT03681470View on ClinicalTrials.gov

Aczone Gel 7.5% in the Treatment of Acne Vulgaris in Patients With Skin of Color

PHASE4CompletedINTERVENTIONAL
Enrollment

20

Participants

Timeline

Start Date

April 9, 2019

Primary Completion Date

May 6, 2021

Study Completion Date

May 6, 2021

Conditions
Acne Vulgaris
Interventions
DRUG

Aczone Gel

Aczone Gel 7.5%

Trial Locations (1)

10023

Mount Sinai West, New York

All Listed Sponsors
lead

Icahn School of Medicine at Mount Sinai

OTHER

NCT03681470 - Aczone Gel 7.5% in the Treatment of Acne Vulgaris in Patients With Skin of Color | Biotech Hunter | Biotech Hunter